Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Broad-spectrum protein substrates" does not refer to a single, specific biological molecule or therapeutic target. Instead, it is a descriptive category used in pharmacology and biochemistry to denote the wide range of proteins that can be acted upon by broad-spectrum enzymes, such as certain proteases or kinases. For example, broad-spectrum proteases like papain or bromelain are used therapeutically to digest a variety of necrotic tissue proteins in wound debridement, while broad-spectrum kinase inhibitors like staurosporine target a vast array of protein kinases across the kinome. Because this term encompasses a heterogeneous group of molecules rather than a specific receptor or enzyme, it is not classified as a canonical drug target in medical literature or databases like UniProt or ChEMBL.
Enzymatic digestion or non-specific inhibition of multiple protein targets
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Broad-spectrum protein substrates.